BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
5.22
-0.08 (-1.51%)
Sep 17, 2025, 3:58 PM EDT
BioStem Technologies Revenue
BioStem Technologies had revenue of $49.30M in the quarter ending June 30, 2025, a decrease of -33.82%. This brings the company's revenue in the last twelve months to $307.26M, up 133.77% year-over-year. In the year 2024, BioStem Technologies had annual revenue of $301.83M with 1,708.93% growth.
Revenue (ttm)
307.26M
Revenue Growth
+133.77%
P/S Ratio
0.28
Revenue / Employee
9.31M
Employees
33
Market Cap
87.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 301.83M | 285.14M | 1,708.93% |
Dec 31, 2023 | 16.69M | 9.81M | 142.69% |
Dec 31, 2022 | 6.88M | 2.53M | 58.38% |
Dec 31, 2021 | 4.34M | 4.03M | 1,284.88% |
Dec 31, 2017 | 313.45K | -293.78K | -48.38% |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
BioStem Technologies News
- 7 days ago - BioStem Technologies, Inc. (BSEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 12 days ago - BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting - GlobeNewsWire
- 15 days ago - BioStem Technologies to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 27 days ago - BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer - GlobeNewsWire
- 4 weeks ago - BioStem Technologies, Inc. (BSEM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - BioStem Technologies Appoints Brandon Poe as Chief Financial Officer - GlobeNewsWire
- 2 months ago - BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes - GlobeNewsWire